Miss Lili Wei

  • Research Assistant (Health Economics & Health Technology Assessment)

Biography

Lili obtained her undergraduate degree in Preventive Medicine, after which she undertook her master degree in Public Health in the University of Glasgow. During her PhD in Public Health, she joined School of Health & Wellbeing as a research assistant since 2020. 

Research interests

Lili is interested in doing quantitative research about the medical data and she is particularly interested in building statistical models to address real-world clinical research questions by using routine health care data and clinical trial data. She also leads on a scoping review about identifying methodological challenges when using routinely collected data for research to inform the further development of a standardised protocol tool. Lili is open for multi-disciplinary researches. She also had some collaborations with some research teams in China, America and Canada. 

Publications

List by: Type | Date

Jump to: 2022 | 2021
Number of items: 2.

2022

Butterly, E. et al. (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol. BMJ Open, 12(10), e066491. (doi: 10.1136/bmjopen-2022-066491) (PMID:36302574) (PMCID:PMC9621152)

2021

Wei, L., Shah, A., Cleland, J. G., Lewsey, J. and McAllister, D. (2021) Assessing the Applicability of Three Heart Failure Randomised Controlled Trials by Calibration to Scottish Registry. Scientific Sessions of the American Heart Association 2021, Boston, MA, USA, 12-15 Nov 2021. A12039. (doi: 10.1161/circ.144.suppl_1.12039)

This list was generated on Mon Jun 5 20:47:43 2023 BST.
Jump to: Articles | Conference or Workshop Item
Number of items: 2.

Articles

Butterly, E. et al. (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol. BMJ Open, 12(10), e066491. (doi: 10.1136/bmjopen-2022-066491) (PMID:36302574) (PMCID:PMC9621152)

Conference or Workshop Item

Wei, L., Shah, A., Cleland, J. G., Lewsey, J. and McAllister, D. (2021) Assessing the Applicability of Three Heart Failure Randomised Controlled Trials by Calibration to Scottish Registry. Scientific Sessions of the American Heart Association 2021, Boston, MA, USA, 12-15 Nov 2021. A12039. (doi: 10.1161/circ.144.suppl_1.12039)

This list was generated on Mon Jun 5 20:47:43 2023 BST.